These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31533665)

  • 1. Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design.
    van Eck van der Sluijs A; Bonenkamp AA; Dekker FW; Abrahams AC; van Jaarsveld BC;
    BMC Nephrol; 2019 Sep; 20(1):361. PubMed ID: 31533665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity is not associated with dialysis modality choice in patients with end-stage kidney disease.
    Bonenkamp AA; Vonk S; Abrahams AC; Vermeeren YM; van Eck van der Sluijs A; Hoekstra T; van Ittersum FJ; van Jaarsveld BC;
    Nephrology (Carlton); 2022 Jun; 27(6):510-518. PubMed ID: 35244316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.
    Dunlop JL; Vandal AC; de Zoysa JR; Gabriel RS; Haloob IA; Hood CJ; Matheson PJ; McGregor DO; Rabindranath KS; Semple DJ; Marshall MR
    BMC Nephrol; 2013 Jul; 14():149. PubMed ID: 23855560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design for SHAREHD: a quality improvement collaborative to scale up Shared Haemodialysis Care for patients on centre based haemodialysis.
    Fotheringham J; Barnes T; Dunn L; Lee S; Ariss S; Young T; Walters SJ; Laboi P; Henwood A; Gair R; Wilkie M
    BMC Nephrol; 2017 Nov; 18(1):335. PubMed ID: 29178891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring experiences and health-related quality of life of caregivers of patients who start home dialysis: study protocol for a prospective, multicentre cohort study.
    van Lieshout TS; Vonk S; Driehuis E; Roeterdink AJ; Goto NA; Vogels T; Kooijman W; Bart J; Broese van Groenou MI; van Jaarsveld BC; Abrahams AC
    BMJ Open; 2022 Nov; 12(11):e064172. PubMed ID: 36356997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial to evaluate and assess the effect of comprehensive pre-end stage kidney disease education on home dialysis use in veterans, rationale and design.
    Shukla AM; Hale-Gallardo J; Orozco T; Freytes I; Purvis Z; Romero S; Jia H
    BMC Nephrol; 2022 Mar; 23(1):121. PubMed ID: 35354430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and health utility of Chinese patients undergoing nocturnal home haemodialysis in comparison with other modes of dialysis.
    Wong CKH; Chen JY; Fung SKS; Lo WK; Lui SL; Chan TM; Cheng YL; Kong I; Wan EYF; Lam CLK
    Nephrology (Carlton); 2019 Jun; 24(6):630-637. PubMed ID: 29926521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIALysis or not: Outcomes in older kidney patients with GerIatriC Assessment (DIALOGICA): rationale and design.
    van Oevelen M; Abrahams AC; Bos WJW; Emmelot-Vonk MH; Mooijaart SP; van Diepen M; van Jaarsveld BC; van Eck van der Sluijs A; Voorend CGN; van Buren M;
    BMC Nephrol; 2021 Jan; 22(1):39. PubMed ID: 33485298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol.
    Target N; Courivaud C; Michel PA; Daoud S; Thomas M
    BMC Nephrol; 2020 Nov; 21(1):500. PubMed ID: 33225917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nocturnal haemodialysis in Australia and New Zealand.
    Agar JW
    Nephrology (Carlton); 2005 Jun; 10(3):222-30. PubMed ID: 15958033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of phosphate binders on quality of life in dialysis patients: Results from the prospective Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes study.
    Colombijn JMT; Vonk S; Cornelis T; Boorsma S; Krekels MME; Abrahams AC; van Jaarsveld BC
    Nephrology (Carlton); 2022 Oct; 27(10):834-844. PubMed ID: 36122909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to successful implementation of care in home haemodialysis (BASIC-HHD):1. Study design, methods and rationale.
    Jayanti A; Wearden AJ; Morris J; Brenchley P; Abma I; Bayer S; Barlow J; Mitra S
    BMC Nephrol; 2013 Sep; 14():197. PubMed ID: 24044499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is health-related quality of life trajectory associated with dialysis modality choice in advanced chronic kidney disease?
    Morin C; Pichette M; Elftouh N; Imbeault B; Laurin LP; Lafrance JP; Goupil R; Nadeau-Fredette AC
    Perit Dial Int; 2024 Jul; 44(4):254-264. PubMed ID: 38186013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of COVID-19 on the mental health of dialysis patients.
    Bonenkamp AA; Druiventak TA; van Eck van der Sluijs A; van Ittersum FJ; van Jaarsveld BC; Abrahams AC;
    J Nephrol; 2021 Apr; 34(2):337-344. PubMed ID: 33742413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in mental health status during the COVID-19 pandemic between patients undergoing in-center hemodialysis and peritoneal dialysis.
    Bouwmans P; Skalli Z; Vernooij RWM; Hemmelder MH; Konijn WS; Lips J; Mulder J; Bonenkamp AA; van Jaarsveld BC; Abrahams AC;
    J Nephrol; 2023 Sep; 36(7):2037-2046. PubMed ID: 37606844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home versus in-centre haemodialysis for end-stage kidney disease.
    Palmer SC; Palmer AR; Craig JC; Johnson DW; Stroumza P; Frantzen L; Leal M; Hoischen S; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009535. PubMed ID: 25412074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home dialysis therapies.
    Corbett RW
    Clin Med (Lond); 2023 May; 23(3):259-261. PubMed ID: 37236788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home haemodialysis in Australia - is the wheel turning full circle?
    Agar JW; Hawley CM; George CR; Mathew TH; McDonald SP; Kerr PG
    Med J Aust; 2010 Apr; 192(7):403-6. PubMed ID: 20367590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.